Next Article in Journal
Cardiovascular and Autonomic Responses to Energy Drinks—Clinical Implications
Next Article in Special Issue
Biphasic Dose-Response Induced by Phytochemicals: Experimental Evidence
Previous Article in Journal
Anesthetic Agents and Cardiovascular Outcomes of Noncardiac Surgery after Coronary Stent Insertion
Previous Article in Special Issue
Antibacterial Activity of Some Flavonoids and Organic Acids Widely Distributed in Plants
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 9
Issue 2
10.3390/jcm9020430
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Curcumin’s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases

by
Bahare Salehi
1,
Daniela Calina
2,*,
Anca Oana Docea
3,
Niranjan Koirala
4,
Sushant Aryal
4,
Domenico Lombardo
5,
Luigi Pasqua
6,
Yasaman Taheri
7,
Carla Marina Salgado Castillo
8,
Miquel Martorell
9,10,*,
Natália Martins
11,12,*,
Marcello Iriti
13,
Hafiz Ansar Rasul Suleria
14 and
Javad Sharifi-Rad
15,*
1
Student Research Committee, School of Medicine, Bam University of Medical Sciences, Bam 44340847, Iran
2
Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
3
Department of Toxicology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
4
Department of Natural Products Research, Dr. Koirala Research Institute for Biotechnology and Biodiversity, Kathmandu 44600, Nepal
5
Italian National Research Council, Rome (CNR), 98158 Messina, Italy
6
Department of Environmental and Chemical Engineering, University of Calabria, 87036 Rende (CS), Italy
7
Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran 1991953381, Iran
8
Facultad de Medicina, Universidad del Azuay, 14-008 Cuenca, Ecuador
9
Department of Nutrition and Dietetics, Faculty of Pharmacy, University of Concepcion, Concepcion 4070386, Chile
10
Unidad de Desarrollo Tecnológico, Universidad de Concepción UDT, Concepcion 4070386, Chile
11
Faculty of Medicine, University of Porto, Alameda Prof. HernâniMonteiro, 4200-319 Porto, Portugal
12
Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal
13
Department of Agricultural and Environmental Sciences, Milan State University, 20133 Milan, Italy
14
Department of Agriculture and Food Systems, The University of Melbourne, Melbourne 3010, Australia
15
Zabol Medicinal Plants Research Center, Zabol University of Medical Sciences, Zabol 61615-585, Iran
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Authors to whom correspondence should be addressed.
J. Clin. Med. 2020, 9(2), 430; https://doi.org/10.3390/jcm9020430
Submission received: 4 January 2020 / Revised: 31 January 2020 / Accepted: 3 February 2020 / Published: 5 February 2020
(This article belongs to the Special Issue Bioactive Phytochemicals in Health and Disease)
Browse Figures
Versions Notes

Abstract

The brain is the body’s control center, so when a disease affects it, the outcomes are devastating. Alzheimer’s and Parkinson’s disease, and multiple sclerosis are brain diseases that cause a large number of human deaths worldwide. Curcumin has demonstrated beneficial effects on brain health through several mechanisms such as antioxidant, amyloid β-binding, anti-inflammatory, tau inhibition, metal chelation, neurogenesis activity, and synaptogenesis promotion. The therapeutic limitation of curcumin is its bioavailability, and to address this problem, new nanoformulations are being developed. The present review aims to summarize the general bioactivity of curcumin in neurological disorders, how functional molecules are extracted, and the different types of nanoformulations available.
Keywords: curcumin; nanocurcumin; neurological disorders; nanocarriers; liposomes curcumin; nanocurcumin; neurological disorders; nanocarriers; liposomes

Share and Cite

MDPI and ACS Style

Salehi, B.; Calina, D.; Docea, A.O.; Koirala, N.; Aryal, S.; Lombardo, D.; Pasqua, L.; Taheri, Y.; Marina Salgado Castillo, C.; Martorell, M.; et al. Curcumin’s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases. J. Clin. Med. 2020, 9, 430. https://doi.org/10.3390/jcm9020430

AMA Style

Salehi B, Calina D, Docea AO, Koirala N, Aryal S, Lombardo D, Pasqua L, Taheri Y, Marina Salgado Castillo C, Martorell M, et al. Curcumin’s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases. Journal of Clinical Medicine. 2020; 9(2):430. https://doi.org/10.3390/jcm9020430

Chicago/Turabian Style

Salehi, Bahare, Daniela Calina, Anca Oana Docea, Niranjan Koirala, Sushant Aryal, Domenico Lombardo, Luigi Pasqua, Yasaman Taheri, Carla Marina Salgado Castillo, Miquel Martorell, and et al. 2020. "Curcumin’s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases" Journal of Clinical Medicine 9, no. 2: 430. https://doi.org/10.3390/jcm9020430

APA Style

Salehi, B., Calina, D., Docea, A. O., Koirala, N., Aryal, S., Lombardo, D., Pasqua, L., Taheri, Y., Marina Salgado Castillo, C., Martorell, M., Martins, N., Iriti, M., Suleria, H. A. R., & Sharifi-Rad, J. (2020). Curcumin’s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases. Journal of Clinical Medicine, 9(2), 430. https://doi.org/10.3390/jcm9020430

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop